Innate immune defenses in the intestinal tract

Current Opinion in Gastroenterology

Volumn 23, Issue 2, 2007, Pages 115-120

  Dann, Sara M ^a   Eckmann, Lars ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Innate immunity; Intestine; Microbial pathogenesis; Mucosal immunology

Indexed keywords

ALPHA DEFENSIN; BACTERICIDAL PERMEABILITY INDUCING PROTEIN; BETA DEFENSIN; CATHELICIDIN; DEFENSIN; LECTIN; PEPTIDE; PROTEIN; RESISTIN LIKE MOLECULE BETA; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIAL VIRULENCE; CROHN DISEASE; EPITHELIUM CELL; HELMINTH; HUMAN; INFECTIOUS DIARRHEA; INNATE IMMUNITY; INTESTINE; INTESTINE MUCOSA; NONHUMAN; PANETH CELL; PROTEIN EXPRESSION; REVIEW;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; HUMANS; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINES; PANETH CELLS;

EID: 33846653740     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32803cadf4     Document Type: Review

References (47)

1. Eckmann L. Sensor molecules in intestinal innate immunity against bacterial infections. Curr Opin Gastroenterol 2006; 22:95-101.
2. Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006; 442:39-44.
3. Ouellette AJ. Paneth cell alpha-defensin synthesis and function. Curr Top Microbiol Immunol 2006; 306:1-25.
4. Ghosh D, Porter E, Shen B, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002; 3:583-590.
5. Weeks CS, Tanabe H, Cummings JE, et al. Matrix metalloproteinase-7 activation of mouse paneth cell pro-alpha-defensins: SER43↓ ILE44 proteolysis enables membrane-disruptive activity. J Biol Chem 2006; 281:28932-28942.
6. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999; 286:113-117.
7. Salzman NH, Ghosh D, Huttner KM, et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003; 422:522-526.
8. Kelly P, Bajaj-Elliott M, Katubulushi M, et al. Reduced gene expression of intestinal alpha-defensins predicts diarrhea in a cohort of African adults. J Infect Dis 2006; 193:1464-1470.
9. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 2005; 102:18129-18134. This paper demonstrates a correlation between decreased intestinal α-defensin levels and the occurrence of ileal Crohn's disease, suggesting that relative α-defensin deficiency may contribute to the disease.
10. Pazgier M, Hoover DM, Yang D, et al. Human beta-defensins. Cell Mol Life Sci 2006; 63:1294-1313.
11. O'Neil DA, Porter EM, Elewaut D, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163:6718-6724.
12. Sherman H, Chapnik N, Froy O. Albumin and amino acids upregulate the expression of human beta-defensin 1. Mol Immunol 2006; 43:1617-1623.
13. Zaalouk TK, Bajaj-Elliott M, George JT, et al. Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infect Immun 2004; 72:2772-2779.
14. Fellermann K, Stange DE, Schaeffeler E, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006; 79:439-448. This important genetic study shows that a decrease in β-defensin-2 gene copy numbers and expression confers an increased risk for developing Crohn's disease, which suggests that reduced defensin expression may be a primary defect responsible for the disease.
15. Fahlgren A, Hammarstrom S, Danielsson A, et al. beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol 2004; 137:379-385.
16. Moser C, Weiner DJ, Lysenko E, et al. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 2002; 70:3068-3072.
17. Morrison G, Kilanowski F, Davidson D, et al. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun 2002; 70:3053-3060.
18. Wehkamp J, Schauber J, Stange EF. Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 2007; 23:32-38.
19. Schauber J, Rieger D, Weiler F, et al. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2006; 18:615-621.
20. Schauber J, Svanholm C, Termen S, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 2003; 52:735-741.
21. Hase K, Eckmann L, Leopard JD, et al. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002; 70:953-963.
22. Raqib R, Sarker P, Bergman P, et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A 2006; 103:9178-9183. This study demonstrates that oral butyrate treatment improves the symptoms and bacteriologic parameters of shigellosis in rabbits, and this effect correlated with increased LL-37 expression, suggesting that epithelium-derived antibiotics may contribute to mucosal defense.
23. Iimura M, Gallo RL, Hase K, et al. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 2005; 174:4901-4907. The study demonstrates that the murine cathelicidin, CRAMP, has a physiologic function in controlling early colonization with an epithelial-adherent bacterial pathogen, and thereby helps to set the threshold for productive infection.
24. Johansson J, Gudmundsson GH, Rottenberg ME, et al. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 1998; 273:3718-3724.
25. Sigurdardottir T, Andersson P, Davoudi M, et al. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother 2006; 50:2983-2989.
26. Steppan CM, Brown EJ, Wright CM, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 2001; 98:502-506.
27. Nair MG, Guild KJ, Artis D. Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy. J Immunol 2006; 177:1393-1399.
28. He W, Wang ML, Jiang HQ, et al. Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology 2003; 125:1388-1397.
29. Artis D, Wang ML, Keilbaugh SA, et al. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci U S A 2004; 101:13596-13600.
30. McVay LD, Keilbaugh SA, Wong TM, et al. Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest 2006; 116:2914-2923.
31. Hogan SP, Seidu L, Blanchard C, et al. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol 2006; 118:257-268.
32. Weiss J. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem Soc Trans 2003; 31:785-790.
33. Canny G, Levy O, Furuta GT, et al. Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci U S A 2002; 99:3902-3907.
34. Canny G, Cario E, Lennartsson A, et al. Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein. Am J Physiol Gastrointest Liver Physiol 2006; 290:G557-G567. This work examines regulated BPI expression in intestinal epithelia, and shows that transgenic BPI expression in epithelial cells kills bacteria in co-culture with the cells.
35. Zhang YW, Ding LS, Lai MD. Reg gene family and human diseases. World J Gastroenterol 2003; 9:2635-2641.
36. Narushima Y, Unno M, Nakagawara K-i, et al. Structure, chromosomal localization and expression of mouse genes encoding type III Reg, RegIIIa, RegIIIb, RegIIIg. Gene 1997; 185:159-168.
37. Christa L, Carnot F, Simon MT, et al. HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am J Physiol Gastrointest Liver Physiol 1996; 271:G993-G1002.
38. Hervieu V, Christa L, Gouysse G, et al. HIP/PAP, a member of the reg family, is expressed in glucagon-producing enteropancreatic endocrine cells and tumors. Hum Path 2006; 37:1066-1075.
39. Cash HL, Whitham CV, Behrendt CL, et al. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006; 313:1126-1130. This work has used a sophisticated gnotobiotic mouse model to demonstrate that commensal bacteria activate Paneth cell expression of the C-type lectin RegIIIγ, which can directly kill susceptible Gram-positive bacteria.
40. Ogawa H, Fukushima K, Naito H, et al. Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm Bowel Dis 2003; 9:162-170.
41. Suzuki YA, Lopez V, Lonnerdal B. Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci 2005; 62:2560-2575.
42. Wrackmeyer U, Hansen GH, Seya T, et al. Intelectin: a novel lipid raft-associated protein in the enterocyte brush border. Biochemistry 2006; 45:9188-9197. This study shows that epithelial cells produce intelectins which can bind to carbohydrate motifs on epithelial and microbial surfaces and thus prevent microbial adhesion and invasion.
43. Pemberton AD, Knight PA, Gamble J, et al. Innate BALB/c enteric epithelial responses to Trichinella spiralis: inducible expression of a novel goblet cell lectin, intelectin-2, and its natural deletion in C57BL/10 mice. J Immunol 2004; 173:1894-1901.
44. Tsuji S, Uehori J, Matsumoto M, et al. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem 2001; 276:23456-23463.
45. Hansen GH, Niels-Christiansen LL, Immerdal L, et al. Antibodies in the small intestine: mucosal synthesis and deposition of antiglycosyl IgA, IgM, and IgG in the enterocyte brush border. Am J Physiol Gastrointest Liver Physiol 2006; 291:G82-G90.
46. Hansen GH, Pedersen ED, Immerdal L, et al. Antiglycosyl antibodies in lipid rafts of the enterocyte brush border: a possible host defense against pathogens. Am J Physiol Gastrointest Liver Physiol 2005; 289:G1100-1107. This paper identifies antiglycosyl antibodies associated with the brush border carbohydrates as potential inhibitors of microbial attachment to the epithelium.
47. Taieb N, Yahi N, Fantini J. Rafts and related glycosphingolipid-enriched microdomains in the intestinal epithelium: bacterial targets linked to nutrient absorption. Adv Drug Deliv Rev 2004; 56:779-794.